Look For Institutional Buying In Day One Biopharmaceuticals Inc (NASDAQ: DAWN)
Day One Biopharmaceuticals Inc (DAWN) concluded trading on Thursday at a closing price of $14.72, with 4.07 million shares of worth about $59.93 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -16.22% during that period and on October 31, 2024 the price saw […]
Analyst Expect Big Moves From Day One Biopharmaceuticals Inc (NASDAQ: DAWN)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Day One Biopharmaceuticals Inc (NASDAQ:DAWN). The institutional investor has increased its shareholding in the Healthcare company by 7.56% to 4.48 million shares with purchase of 0.31 million shares. This fresh investment now brings its stake to 5.14% valued currently at $51.83 million. In […]
